
    
      Patients over 45 years of age with one or more AVV symptoms who wish to participate in the
      study will be included, 2 laser sessions spaced one of another 4-6 weeks, and final tracking
      visit 4-6 weeks of the last laser session.

      Each patient shall be randomly assigned an arm of tto, with laser CO2, or laser Erbium, or
      sham group
    
  